Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVJF) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Teva Pharmaceutical Industries (TEVJF) over the last 10 years, with Q2 2025 value amounting to $2.3 billion.

  • Teva Pharmaceutical Industries' Long-Term Debt Issuances changed N/A to $2.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 billion, marking a year-over-year change of. This contributed to the annual value of $2.3 billion for FY2025, which is N/A changed from last year.
  • Teva Pharmaceutical Industries' Long-Term Debt Issuances amounted to $2.3 billion in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Long-Term Debt Issuances ranged from a high of $2.5 billion in Q1 2023 and a low of $2.3 billion during Q2 2025